Fitbit and AI Chatbot in Sedentary Primary Care Patients With T2D

Recruiting Observational Study
Type 2 Diabetes Type 2 Diabetes Mellitus (T2DM) T2DM (Type 2 Diabetes Mellitus) T2D T2DM Remote Patient Monitoring Artificial Intelegence
No Placebo Group Every participant receives an active treatment — no one gets a placebo. No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 – 80
Sex
Any
Study type
Observational
Participants needed
36 (estimated)
Sponsor
University of Colorado, Denver · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
The goal of this observational study is to evaluate the feasibility and acceptability of a 12-week intervention utilizing a Fitbit and artificial intelligence (AI)-delivered diabetes self-management education and support (DSMES) with tailored text messages. The main question it aims to answer is: Does providing a wearable fitness and activity tracker plus AI-tailored and DSMES improve clinical o…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Diagnosed with type 2 diabetes per investigator discretion * No more than 20% of the sample will have A1c \< 7.5% (confirmed by medical record review or an A1c completed within 3 months of the screening visit) * Age ≥18 years and ≤ 80 years * Does not meet ADA guidelines for p…
Contacts

Jessica Parascando, MPH

303-724-9525

jessica.parascando@cuanschutz.edu

CONTACT

Elizabeth Westfeldt, BSN, RN

elizabeth.westfeldt@cuanschutz.edu

CONTACT